Autoinflammatory Withdrawn Phase 1 / 2 Trials for Gevokizumab (DB12119)

IndicationStatusPhase
DBCOND0048641 (Autoinflammatory)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01211977A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's DiseaseTreatment